UBS Initiates Coverage of Shoulder Innovations (SI) with Buy Recommendation
Shoulder Innovations Inc SI
$22.74
▼ -1.94%
($-0.45)
⬇️ Below Yest. Low
📅 Earnings This Week
Open
$23.00
Prev Close
$23.19
Day Range
$22.44 – $23.25
52W Range
$10.92 – $24.60
Market Cap
$471.59M
Beta
14.86
EPS (TTM)
$-1.01
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2025-07-31 |
| Shares Out. | 20,740,000 |
| Website | shoulderinnovations.com/ ↗ |
| Phone | 13026587581 |
| Employees | 75 |
| Revenue | $16.7M |
| Gross Profit | $13.0M |
| Net Income | -$8.4M |
| Free Cash Flow | -$44.8M |
| Total Assets | $160.4M |
| Total Liabilities | $27.3M |
| Equity | $133.0M |
About Shoulder Innovations Inc
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
Shoulder Innovations Inc is a publicly traded company under the ticker symbol SI on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-07-01)